- Type / Class
- Equity / Common Stock
- Shares outstanding
- 235,704,040
- Total 13F shares
- 8,389,293
- Share change
- -33,071
- Total reported value
- $67,868,000
- Price per share
- $8.09
- Number of holders
- 21
- Value change
- -$263,290
- Number of buys
- 12
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 000899104?
CUSIP 000899104 identifies ADMA - ADMA BIOLOGICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 000899104:
Top shareholders of ADMA - ADMA BIOLOGICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Aisling Capital LLC |
13F
|
Company |
1.5%
|
3,608,171
|
$29,118,000 | — | 31 Dec 2015 | |
| Biomark Capital Management Co. LLC |
13F
|
Company |
0.61%
|
1,433,304
|
$11,567,000 | — | 31 Dec 2015 | |
| Consonance Capital Management LP |
13F
|
Company |
0.45%
|
1,060,017
|
$8,554,000 | — | 31 Dec 2015 | |
| Broadfin Capital, LLC |
13F
|
Company |
0.41%
|
964,193
|
$7,781,000 | — | 31 Dec 2015 | |
| FMR LLC |
13F
|
Company |
0.18%
|
423,100
|
$3,431,000 | — | 31 Dec 2015 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.11%
|
254,999
|
$2,068,000 | — | 31 Dec 2015 | |
| PointState Capital LP |
13F
|
Company |
0.09%
|
203,158
|
$1,639,000 | — | 31 Dec 2015 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.07%
|
160,000
|
$1,291,000 | — | 31 Dec 2015 | |
| J. Goldman & Co LP |
13F
|
Company |
0.05%
|
121,756
|
$983,000 | — | 31 Dec 2015 | |
| Telemetry Investments, L.L.C. |
13F
|
Company |
0.02%
|
45,000
|
$365,000 | — | 31 Dec 2015 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.02%
|
36,400
|
$295,000 | — | 31 Dec 2015 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.01%
|
26,411
|
$214,000 | — | 31 Dec 2015 | |
| GUGGENHEIM CAPITAL LLC |
13F
|
Company |
0.01%
|
17,532
|
$142,000 | — | 31 Dec 2015 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.01%
|
16,077
|
$130,000 | — | 31 Dec 2015 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
13,243
|
$107,000 | — | 31 Dec 2015 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
12,000
|
$97,000 | — | 31 Dec 2015 | |
| Spark Investment Management LLC |
13F
|
Company |
0%
|
11,000
|
$88,000 | — | 31 Dec 2015 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
6,452
|
$52,000 | — | 31 Dec 2015 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
4,000
|
$32,000 | — | 31 Dec 2015 | |
| Mount Lucas Management LP |
13F
|
Company |
0%
|
3,500
|
$28,000 | — | 31 Dec 2015 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0%
|
708
|
$6,000 | — | 31 Dec 2015 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
500
|
$4,000 | — | 31 Dec 2015 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
434
|
$4,000 | — | 31 Dec 2015 | |
| BlackRock Fund Advisors |
13F
|
Company |
0%
|
409
|
$3,000 | — | 31 Dec 2015 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
100
|
$1,000 | — | 31 Dec 2015 |
Institutional Holders of ADMA BIOLOGICS, INC. - Common Stock (ADMA) as of Q1 2016
As of 31 Mar 2016,
ADMA BIOLOGICS, INC. - Common Stock (ADMA) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,389,293 shares.
The largest 10 holders included
Aisling Capital LLC, Biomark Capital Management Co. LLC, Consonance Capital Management LP, Broadfin Capital, LLC, FMR LLC, FRANKLIN RESOURCES INC, Weiss Multi-Strategy Advisers LLC, J. Goldman & Co LP, VANGUARD GROUP INC, and Telemetry Investments, L.L.C..
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2016 vs Q4 2015 Across Filers
Q4 2015 holders
24
Q1 2016 holders
21
Holder diff
-3
| Investor | Q4 2015 Shares | Q1 2016 Shares | Share Diff | Share Chg % | Q4 2015 Value $ | Q1 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.